Literature DB >> 17400294

Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.

Masato Kikuchi1, Makoto Nakamura, Kohei Ishikawa, Toshimitsu Suzuki, Hiroaki Nishihara, Tomomi Yamakoshi, Kazuko Nishio, Kentaro Taki, Toshimitsu Niwa, Nobuyuki Hamajima, Hiroko Terasaki.   

Abstract

PURPOSE: To determine the relationship between systemic C-reactive protein (CRP) levels and polypoidal choroidal vasculopathy (PCV) and advanced neovascular age-related macular degeneration (AMD) in Japanese patients.
DESIGN: Case-control study. PARTICIPANTS: Ninety-seven patients with PCV, 176 with advanced neovascular AMD, and 262 control subjects without any macular abnormality were studied.
METHODS: Color fundus photographs of the macular area were taken from both eyes in all subjects. Indocyanine green angiography and fluorescein angiography were performed for diagnosis. The CRP level was measured by a high-sensitivity assay using a latex aggregation immunoassay, and the levels in patients with PCV and neovascular AMD were compared with that in the control group using the Kruskal-Wallis test. Associations between CRP and PCV or neovascular AMD were compared using logistic regression analysis by computing the odds ratios (ORs) and 95% confidence intervals (CIs) after the study populations were divided into quartiles. MAIN OUTCOME MEASURES: The CRP levels in patients with PCV, patients with neovascular AMD, and control subjects. Standard univariate and multivariate analyses between groups.
RESULTS: Median CRP levels were significantly higher in cases with PCV (0.94 mg/l) or with advanced neovascular AMD (0.95 mg/l) than in control subjects (0.43 mg/l) (P<0.001 for Kruskal-Wallis test). After adjusting for baseline characteristics such as age, gender, smoking status, alcohol use, body mass index, history, and use of antiinflammatory drugs, the increase in risk was significant for the highest quartile of CRP for both PCV (OR, 3.53; 95% CI, 1.49-8.40) and neovascular AMD (OR, 4.08; 95% CI, 1.94-8.56), and for the third quartile of CRP for neovascular AMD (OR, 2.29; 95% CI, 1.07-4.91). The trends for an increase in risk of disease with increase in CRP were statistically significant for both PCV (P = 0.001) and neovascular AMD (P<0.001).
CONCLUSIONS: The significant associations between elevated serum CRP levels and PCV or neovascular AMD in the Japanese strongly suggest that inflammatory processes are involved in the pathogenesis of PCV and neovascular AMD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400294     DOI: 10.1016/j.ophtha.2006.12.021

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  38 in total

1.  A comparison of risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese patients.

Authors:  Xiao-Li Chen; Qin-Rui Hu; Yu-Jing Bai; Yu Deng; Hai-Wei Wang; Shan Liu; Yin-Lin Wang; Yan-Kun Yue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

Review 2.  Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment.

Authors:  Narendra Dhingra; Susan Kelly; Mohammed A Majid; Claire B Bailey; Andrew D Dick
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

3.  [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy].

Authors:  Yi Zhang; Jing Yao; Xiao-Hua Wang; Lin Zhao; Li-Jun Wang; Jian-Ming Wang; Ai-Yi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

4.  C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration.

Authors:  Roham Soheilian; Mohammad Hossein Jabbarpour Bonyadi; Hamidreza Moein; Mojgan Babanejad; Alireza Ramezani; Mehdi Yaseri; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2016-10-24       Impact factor: 2.031

Review 5.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 6.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

7.  ARMS2 interference leads to decrease of proinflammatory mediators.

Authors:  Fanxing Zeng; Min Zhang; Yiting Xu; Haifeng Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-20       Impact factor: 3.117

8.  Monozygotic twins with polypoidal choroidal vasuculopathy.

Authors:  Shigeki Machida; Tomomi Takahashi; Norimoto Gotoh; Nagahisa Yoshimura; Takamitsu Fujiwara; Dajiro Kurosaka
Journal:  Clin Ophthalmol       Date:  2010-07-30

9.  SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Naoshi Kondo; Hiroaki Bessho; Shigeru Honda; Akira Negi
Journal:  Mol Vis       Date:  2009-09-09       Impact factor: 2.367

10.  SERPING1 polymorphisms in polypoidal choroidal vasculopathy.

Authors:  Meng Li; Feng Wen; Chengguo Zuo; Xiongze Zhang; Hui Chen; Shizhou Huang; Guangwei Luo
Journal:  Mol Vis       Date:  2010-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.